{"schema_version":"1","generated_at":"2026-10-29T16:24:53.518Z","data_as_of":"2026-10-25","url":"https://www.findmykol.com/kol/brandon-imber","json_url":"https://www.findmykol.com/kol/brandon-imber/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"brandon-imber","name":"Brandon Imber","credential":"MD","title":"Assistant Attending Radiation Oncologist","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Lymphoma","therapeutic_areas":["Lymphoma","Neuro-Oncology"],"institution":"Memorial Sloan Kettering Cancer Center","institution_url":"https://www.findmykol.com/institution/memorial-sloan-kettering-cancer-center","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1275928871","orcid":"0000-0002-1281-5915","openalex":"A5023759382"},"summary":"Brandon Imber is Assistant Attending Radiation Oncologist at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 319 publications with 2,340 citations (h-index 27); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.","overview":{"text":"Brandon Imber, M.D., is Assistant Attending Radiation Oncologist at Memorial Sloan Kettering Cancer Center. The public record shows 319 publications with 2,340 citations (h-index 27), centered on Lymphoma Diagnosis and Treatment, Brain Metastases and Treatment, Glioma Diagnosis and Treatment. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 4 companies.","bullets":["Most recent indexed publication: 2026 · Journal of clinical oncology","Top research focus: Lymphoma Diagnosis and Treatment","7 registered trials on ClinicalTrials.gov","Open Payments reporting from 4 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":2,"topics":1,"strength":7},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":2,"topics":1,"strength":7},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell, Cutaneous","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, Follicular","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Lymphoma Diagnosis and Treatment","Brain Metastases and Treatment","Glioma Diagnosis and Treatment","CAR-T cell therapy research","Management of metastatic bone disease"],"drugs_studied":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Gozetotide","trials":0,"payments":7,"publications":0,"mentions":7},{"name":"Azd-1390","trials":1,"payments":0,"publications":0,"mentions":1}]},"works_with":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"GT Medical Technologies, Inc","trials":0,"payments":37,"mentions":37},{"name":"Memorial Sloan Kettering Cancer Center","trials":6,"payments":0,"mentions":6},{"name":"Telix Pharmaceuticals","trials":0,"payments":6,"mentions":6}]}},"scholarship":{"works_count":319,"cited_by_count":2340,"h_index":27,"i10_index":48,"pubmed_count":32,"latest_activity_year":2026,"source":"works"},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07223034","title":"A Study of 177Lu-PSMA-617 in People With Gliomas","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT07223034","trial_url":"https://www.findmykol.com/trial/NCT07223034"},{"nct":"NCT07029217","title":"A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT07029217","trial_url":"https://www.findmykol.com/trial/NCT07029217"},{"nct":"NCT05296304","title":"A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05296304","trial_url":"https://www.findmykol.com/trial/NCT05296304"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":2025},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"GT Medical Technologies, Inc","program_year":2025,"amount_usd":24158.69,"payment_count":20,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275928871"},{"payer":"Telix Pharmaceuticals","program_year":2025,"amount_usd":167.72,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275928871"},{"payer":"GT Medical Technologies, Inc","program_year":2024,"amount_usd":3141.55,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275928871"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1275928871","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Sensory organs","share_pct":63.5,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":63.5,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":40}]},{"area":"Nervous system","share_pct":18.8,"classes_total":1,"classes":[{"class":"Benzodiazepine","setting":"prescribed","share_pct":18.8,"drugs":[{"name":"Lorazepam","share_pct":100}],"max_beneficiaries":17}]},{"area":"Metabolism & gastrointestinal","share_pct":17.7,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":17.7,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":68.3,"facility_pct":31.7},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":90,"years":{"first":2014,"last":2026},"societies":["AACR","ASCO","ASH","ASTRO"],"shown":3,"withheld":87,"rows":[{"title":"Abstract 2116: Genomic landscape of 1007 pan-cancer brain metastases.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-2116","source_url":"https://doi.org/10.1158/1538-7445.am2026-2116","status":"verified"},{"title":"Final results of a randomized, controlled, phase 3 trial comparing resection and post-operative stereotactic radiation versus resection and cesium-131 tile-based radiation for treatment of newly diagnosed brain metastases.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.17_suppl.lba2000","source_url":"https://doi.org/10.1200/jco.2026.44.17_suppl.lba2000","status":"verified"},{"title":"Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco-26-01894","source_url":"https://doi.org/10.1200/jco-26-01894","status":"verified"}],"source":"congress"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42804720/","status":"verified"},{"title":"Linac-based stereotactic radiosurgery for brain metastases: Survival and salvage treatment in a contemporary cohort of 3893 patients.","year":2026,"journal":"Neuro-oncology advances","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42840915/","status":"verified"},{"title":"Brain metastases among older people with cancer.","year":2026,"journal":"Journal of the National Cancer Institute","types":["Editorial","Comment"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42275190/","status":"verified"},{"title":"Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma.","year":2026,"journal":"Blood cancer journal","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42618556/","status":"verified"},{"title":"Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42054619/","status":"verified"}],"most_cited":{"total":319,"shown":5,"withheld":314,"rows":[{"title":"Global and regional functional connectivity maps of neural oscillations in focal epilepsy","year":2015,"cited_by_count":236,"type":"article","source_url":"https://doi.org/10.1093/brain/awv130"},{"title":"Epileptogenic zone localization using magnetoencephalography predicts seizure freedom in epilepsy surgery","year":2015,"cited_by_count":151,"type":"article","source_url":"https://doi.org/10.1111/epi.13002"},{"title":"Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma","year":2024,"cited_by_count":108,"type":"article","source_url":"https://doi.org/10.1200/jco.23.01308"},{"title":"Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma","year":2022,"cited_by_count":102,"type":"article","source_url":"https://doi.org/10.1038/s41375-022-01739-2"},{"title":"Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer","year":2017,"cited_by_count":86,"type":"article","source_url":"https://doi.org/10.1073/pnas.1701821114"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Joachim Yahalom","coauthored_works":143,"profile_url":"https://www.findmykol.com/kol/joachim-yahalom"},{"name":"Carla Hajj","coauthored_works":67,"profile_url":"https://www.findmykol.com/kol/carla-hajj"},{"name":"Beatrice Fregonese","coauthored_works":65}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/brandon-imber-md","status":"verified"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://mskcc.org/cancer-care/doctors/brandon-imber","platform":"other","status":"verified"},{"url":"https://synapse.mskcc.org/synapse/people/17876","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, University of California, San Francisco School of Medicine","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"},{"value":"MA, Chemical Biology, Harvard University","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"Chief Resident, Radiation Oncology, Memorial Sloan Kettering Cancer Center (2020)","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"},{"value":"Member, Lymphoma Disease Management Team and MSK Brain Metastasis Center","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"}]},"awards":{"total":5,"shown":3,"rows":[{"value":"Abstract Award, American Society of Hematology (2019)","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"},{"value":"Resident Research Grant, American College of Radiation Oncology (2018)","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"},{"value":"Dr. Mortimer J. Lacher, MD Fellowship award in Lymphoma, Memorial Sloan Kettering Cancer Center (2018)","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Describes himself as an early drug development specialist who tests new drugs to treat cancer","source_url":"https://www.mskcc.org/cancer-care/doctors/brandon-imber","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"},{"name":"Mark Kris","slug":"mark-kris","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mark-kris","json_url":"https://www.findmykol.com/kol/mark-kris/profile.json"},{"name":"Seth Steinberg","slug":"seth-steinberg","institution":"National Cancer Institute (NCI)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/seth-steinberg","json_url":"https://www.findmykol.com/kol/seth-steinberg/profile.json"},{"name":"Gilles Salles","slug":"gilles-salles","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/gilles-salles","json_url":"https://www.findmykol.com/kol/gilles-salles/profile.json"},{"name":"Thomas Witzig","slug":"thomas-witzig","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/thomas-witzig","json_url":"https://www.findmykol.com/kol/thomas-witzig/profile.json"},{"name":"Wyndham Wilson","slug":"wyndham-wilson","institution":"National Cancer Institute (NCI)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/wyndham-wilson","json_url":"https://www.findmykol.com/kol/wyndham-wilson/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":8,"congress":87,"publications":27,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}